Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director departure

COMPLETE GENOMICS INC (GNOM) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/19/2013 8-K Quarterly results
11/09/2012 8-K Quarterly results
Docs: "Complete Genomics Reports Third Quarter 2012 Results"
09/17/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Agreement and Plan of Merger, by and among BGI-Shenzhen, Beta Acquisition Corporation and Complete Genomics, Inc",
"Tender and Support Agreement, by and among BGI-Shenzhen, Beta Acquisition Corporation, Clifford A. Reid, C. Thomas Caskey, Lewis J. Shuster, Charles P. Waite, Jr., Robert T. Wall, A. W. Homan, Ajay Bansal, Keith Raffel, Radoje T. Drmanac, OVP Venture Partners (and affiliated entities) and Essex Woodlands Health Ventures (and affiliated entities)",
"Convertible Subordinated Promissory Note, by and among BGI-Shenzhen, BGI-HONGKONG Co., Limited and Complete Genomics, Inc",
"Amendment to Loan and Security Agreement, by and between Oxford Finance LLC and Complete Genomics, Inc",
"Complete Genomics and BGI-Shenzhen Announce Definitive Agreement to Merge ~ Combination will create a global innovator in whole human genomic sequencing ~ Mountain View, CA and Shenzhen, China — Sept. 17, 2012 - Complete Genomics, Inc. , an innovative leader in whole human genomic sequencing, and BGI-Shenzhen , a leading international genomics company based in Shenzhen, China, today announced that they have entered into a definitive merger agreement. Through this agreement, a wholly-owned U.S. subsidiary of BGI will launch a tender offer to purchase all outstanding shares of common stock of Complete for $3.15 per share in cash, without interest. This price represents approximately a 54% premium to the $2.04 closing price per share of Complete common stock on June 4, 2012, the last trading ..."
09/06/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/02/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/25/2012 8-K Submission of Matters to a Vote of Security Holders
06/06/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/05/2012 8-K Form 8-K - Current report
05/07/2012 8-K Quarterly results
Docs: "Complete Genomics Reports First Quarter 2012 Results"
03/22/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/12/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Opinion of Latham & Watkins LLP",
"At Market Issuance Sales Agreement between Complete Genomics, Inc. and MLV & Co. LLC"
03/08/2012 8-K Quarterly results
Docs: "Complete Genomics Reports Fourth Quarter and Fiscal Year 2011 Results"
01/10/2012 8-K Form 8-K - Current report
11/28/2011 8-K Other Events
11/08/2011 8-K Form 8-K - Current report
11/03/2011 8-K/A Form 8-K - Current report [amend]
08/03/2011 8-K Quarterly results
Docs: "Complete Genomics Reports Results for Second Quarter 2011"
06/27/2011 8-K Form 8-K - Current report
06/27/2011 8-K Form 8-K - Current report
06/01/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Complete Genomics Announces Closing of Public Offering and Exercise of Over-Allotment Option"
05/26/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Complete Genomics Announces Pricing of Public Offering"
05/11/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/15/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/10/2011 8-K Form 8-K - Current report
03/09/2011 8-K Form 8-K - Current report
12/17/2010 8-K Form 8-K - Current report
11/16/2010 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy